FDA Unveils Adverse Event Reporting Rules For Combination Products
This article was originally published in The Gray Sheet
Executive Summary
FDA says its proposed adverse event reporting requirements for combination products will help manufacturers navigate the intricate array of reporting requirements for deaths and injuries
You may also be interested in...
2016 Will Be A Big Year For Combo Product Reform, FDA Says
Having earlier signaled its plan to propose a new statutory pathway for combination products by the end of 2016, the agency is now working on a bevy of process changes, guidance documents and rules to enhance premarket and postmarket regulation of combination products in the years ahead.
2016 Will Be A Big Year For Combo Product Reform, FDA Says
The agency has already signaled its plan to propose a new statutory pathway for combination products by the end of next year. In the meantime, it's working on a bevy of process changes, guidance documents and rules to enhance premarket and postmarket regulation of combination products in the years ahead. Office of Combination Products officials John Weiner and Thinh Nguyen weigh in.
UDI Final Rule Listed For July Release In HHS Regulatory Agenda
The UDI final rule is among 11 device-focused proposed and final regulations included in the HHS unified agenda of regulations planned through early 2014, and it is likely the most closely watched of the group by industry.